UnitedHealth Group Incorporated is trading 5.9% up at $399.25 after a significant analyst upgrade provided a strong catalyst for the shares.
- Bank of America upgraded UNH from “neutral” to “buy” and raised its price target to $450 from $420, citing a favorable outlook for Q2 earnings driven by improved medical cost trends.
- The stock is significantly outperforming the broader market; while the Dow Jones Industrial Average has gained 1.4%, the S&P 500 and Nasdaq are trading lower.
- While broader market themes like heightened U.S.-Iran tensions exist, the primary driver for today's outperformance appears to be this company-specific positive analyst action.